Mounjaro (Tirzepatide) Weight Loss Injections – KwikPen

Buy Mounjaro from £125 — includes a free prescription and discreet UK delivery.

Key highlights

• Buy Mounjaro once-weekly injection for weight loss
• Dual GIP and GLP-1 action reduces appetite and calorie intake
• Average weight loss of up to 20–22.5% of starting body weight over 72 weeks in clinical trials
• Dose escalation from 2.5 mg to 15 mg for personalised treatment
• Pre-filled KwikPen auto-injector for simple, accurate self-injection
• MHRA-approved for chronic weight management in adults

What Is the Mounjaro Weight Loss Injection?

The Mounjaro weight-loss injection is a once-weekly subcutaneous injection containing tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Developed by Lilly, it was approved by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) for chronic weight management in adults. If you have been struggling with your weight despite diet and exercise changes, this treatment may be worth discussing with a clinician. You can explore the full range of options available through our weight loss collection.

Mounjaro is available in the KwikPen format — a pre-filled, single-use auto-injector that makes self-administration straightforward. Each pen delivers a precise, fixed dose, removing the need for manual drawing up of medication. It comes in multiple strengths to support a gradual dose escalation approach, which helps your body adjust and reduces the likelihood of side effects.

How Does the Mounjaro KwikPen Work in the Body?

Tirzepatide works through a dual mechanism that sets it apart from earlier weight loss injections. Here is how it acts step by step:

• GLP-1 receptor activation: Slows gastric emptying, reduces appetite, and lowers post-meal blood glucose levels.
• GIP receptor activation: Enhances insulin secretion in a glucose-dependent manner and may improve fat metabolism.
• Hypothalamic signalling: Both pathways signal to the brain's appetite-regulating centres, reducing hunger and increasing feelings of fullness.
• Caloric intake reduction: The combined effect leads to a meaningful reduction in daily calorie consumption over time.

Because tirzepatide targets two separate receptor pathways simultaneously, it produces a more pronounced effect on appetite and weight than single-receptor agents. Clinical trial data from the SURMOUNT programme demonstrated significant average body weight reductions in participants using tirzepatide compared to placebo.

Who Is Suitable for the Mounjaro Tirzepatide Injection?

Mounjaro is a prescription-only medicine, so a clinical assessment is required before it can be dispensed. It is indicated for adults who meet specific criteria and are committed to making lifestyle changes alongside treatment. It is not a standalone solution — it works best when combined with a calorie-controlled diet and regular physical activity.

You may be suitable for Mounjaro if you:

• Have a BMI of 30 kg/m² or above (obesity)
• Have a BMI of 27 kg/m² or above with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidaemia
• Are an adult aged 18 or over
• Have not responded adequately to diet and lifestyle interventions alone

How Does Mounjaro Compare to Other Weight Loss Injections?

What Is Mounjaro and What Is It Used For?

Mounjaro (tirzepatide) is a prescription-only injectable medicine used for chronic weight management in adults. It belongs to a class of medicines known as incretin mimetics and works by mimicking the actions of two naturally occurring gut hormones — GIP and GLP-1 — that regulate appetite and blood sugar. The NHS recognises obesity as a complex, long-term condition, and treatments like tirzepatide are intended to support sustained weight loss as part of a broader lifestyle programme.

Mounjaro is not a quick fix. It is designed for people who have not achieved adequate weight loss through diet and exercise alone and who meet the clinical criteria for treatment. It is injected once weekly under the skin, typically in the abdomen, thigh, or upper arm.

What Do You Need to Know Before Using Mounjaro?

Before starting Mounjaro, your prescriber will review your full medical history. There are important contraindications and warnings to be aware of:

• Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC)
• Do not use if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Do not use if you are pregnant, planning to become pregnant, or breastfeeding
• Use with caution if you have a history of pancreatitis — seek immediate medical advice if you develop severe abdominal pain
• Not recommended for people with severe gastrointestinal disease, including gastroparesis
• Use with caution in people with diabetic retinopathy, as rapid glucose improvements may temporarily worsen this condition
• Not indicated for type 1 diabetes

The following medicines may interact with Mounjaro and should be discussed with your prescriber or pharmacist:

• Insulin and sulfonylureas — increased risk of hypoglycaemia when used together
• Oral contraceptives — tirzepatide may reduce absorption; additional contraceptive precautions may be needed for four weeks after starting or dose escalation
• Other medicines with narrow therapeutic windows that depend on consistent gastric absorption

How Should You Use the Mounjaro KwikPen?

Always follow your prescriber's instructions. The general dosing approach for Mounjaro follows a gradual escalation schedule to minimise gastrointestinal side effects. Here are the steps for using the KwikPen:

1. Remove the pen from the fridge and allow it to reach room temperature for approximately 30 minutes before injecting.
2. Wash your hands thoroughly with soap and water.
3. Choose your injection site — abdomen, front of thigh, or upper arm. Rotate sites each week.
4. Clean the skin with an alcohol swab and allow it to dry.
5. Remove the base cap from the KwikPen and press firmly against the skin until you hear a click.
6. Hold the pen in place for at least 10 seconds to ensure the full dose is delivered.
7. Dispose of the used pen in a sharps bin immediately after use.

Mounjaro can be injected at any time of day, with or without food — there is no requirement to take it at a specific time relative to meals. The most important thing is consistency: choose a day of the week that fits your routine and stick to it, as this helps maintain stable drug levels throughout your treatment. If you need to change your injection day, ensure there is a minimum gap of three days between your previous and new injection.

Mounjaro is intended for long-term use as part of a sustained weight management programme. Clinical trials have evaluated its use over periods of up to 72 weeks, and treatment is generally continued for as long as it remains effective and well tolerated. Your prescriber will review your progress regularly and advise on whether to continue, adjust, or stop treatment. Weight regain is common after stopping tirzepatide, so any decision to discontinue should be made collaboratively with your healthcare team rather than abruptly.

Do not exceed the recommended dose. If in doubt, speak to your pharmacist.

What Are the Possible Side Effects of Mounjaro?

Like all medicines, Mounjaro can cause side effects, though not everyone experiences them. Gastrointestinal effects are the most frequently reported and are usually most noticeable during dose escalation. If nausea is a concern, eating smaller meals and avoiding high-fat foods can help. You might also find it useful to browse our sickness and nausea range for supportive remedies.

Common side effects (may affect more than 1 in 10 people):

• Nausea
• Diarrhoea
• Vomiting
• Constipation
• Reduced appetite
• Abdominal discomfort or bloating

Less common side effects (may affect up to 1 in 10 people):

• Injection site reactions (redness, itching, bruising)
• Fatigue
• Dizziness
• Hypoglycaemia (particularly if used with insulin or sulfonylureas)
• Hair loss (telogen effluvium — often temporary and related to rapid weight loss)
• Gastro-oesophageal reflux

Serious side effects (uncommon but require prompt medical attention):
Pancreatitis — inflammation of the pancreas — has been reported in people using GLP-1 receptor agonists. If you develop severe, persistent abdominal pain that may radiate to your back, stop using Mounjaro and seek urgent medical advice immediately. There is a theoretical risk of thyroid C-cell tumours based on animal studies, which is why Mounjaro is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2. Serious allergic reactions (anaphylaxis or angioedema) are rare but require emergency treatment — signs include swelling of the face, lips, tongue, or throat, difficulty breathing, or a rapid heartbeat.

Keep a note of any side effects you experience and when they occur, as this information will be useful at your next prescriber review. You can also report suspected side effects directly to the MHRA via the Yellow Card Scheme.

Can Mounjaro Interact With Other Medicines?

Yes — Mounjaro can interact with certain medicines, and it is important to inform your prescriber and pharmacist of everything you are currently taking, including over-the-counter products and supplements. Because tirzepatide slows gastric emptying, it may affect the absorption rate of oral medicines taken at the same time. The most clinically significant interactions include insulin and sulfonylureas (increased hypoglycaemia risk) and oral contraceptives (reduced absorption during the first four weeks of treatment or after a dose increase — additional contraceptive precautions may be required). Always seek advice before starting any new medicine while using Mounjaro.

How Should You Store the Mounjaro KwikPen?

Correct storage is essential to maintain the integrity of the medication. Keep your Mounjaro KwikPen in the refrigerator at 2°C to 8°C until you are ready to use it. Do not freeze it — if a pen has been frozen, discard it. Once removed from the fridge, the pen can be stored at room temperature below 30°C for up to 21 days. Always keep it in the original carton to protect it from light. Never use a pen that appears cloudy, discoloured, or contains visible particles. Check the expiry date before each injection and dispose of used pens safely in a sharps bin.

If you are also managing blood glucose levels alongside your weight, it may be helpful to browse our diabetes monitoring range for compatible testing supplies.

This product is a medicine. Speak to your doctor or pharmacist before using if you have an underlying medical condition or are taking other medicines.

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen specifications

How Much Does It Cost to Buy Mounjaro in the UK?

The price of Mounjaro reflects the full service you're paying for — a genuine clinical assessment, a prescription from a GPhC-registered pharmacist prescriber, and dispensing from a UK-based pharmacy, not just the pen itself. Pricing rises with strength, since each dose escalation step uses a higher-concentration KwikPen. At Cured Pharmacy, prices start from £145 for the 2.5 mg starting dose, rising to £287 for the maximum 15 mg maintenance dose, with a free prescription included.

Mounjaro is available on the NHS in England for some patients who meet strict BMI and comorbidity criteria, though access varies by local commissioning and can involve a waiting list. Private prescribing — including through a registered online pharmacy — offers a faster route for eligible adults who complete a proper clinical assessment.

If you're comparing prices between providers, it's worth checking a few things before you buy:

• The pharmacy is GPhC-registered — you can verify this on the GPhC register
• A genuine clinical questionnaire or consultation is part of the process, not just a checkout page
• What's included in the price — some providers charge separately for follow-up consultations and dose changes
• The pen is dispatched from a UK pharmacy in proper cold-chain packaging, since Mounjaro must be kept refrigerated in transit

Prices that sit well below the rest of the market are worth treating with caution. Counterfeit and improperly stored GLP-1/GIP injectables have been identified circulating outside regulated pharmacy channels in the UK, and the MHRA has issued repeated warnings about this medicine class. A verified, GPhC-registered pharmacy offering transparent pricing for a proper clinical service is a safer basis for comparison than price alone.

References

1. https://www.nhs.uk/conditions/obesity/
2. https://www.nhs.uk/conditions/type-2-diabetes/managing-type-2-diabetes/treating-type-2-diabetes/
3. https://www.nhs.uk/conditions/pancreatitis/
4. https://www.nhs.uk/conditions/weight-loss-surgery/
5. https://www.medicines.org.uk/emc/product/15484